Discontinued — last reported Q4 '18
Roivant Sciences EPS (Basic, Continuing) decreased by 123.5% to $-0.38 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 72.7%, from $-0.22 to $-0.38. Over 2 years (FY 2021 to FY 2024), EPS (Basic, Continuing) shows an upward trend with a -22.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values signal better profitability per share, which often supports stock price appreciation and dividend potential.
Basic earnings per share from continuing operations measures the portion of a company's profit allocated to each outstan...
Widely used by analysts to compare the per-share profitability of companies within the same sector, regardless of total company size.
eps_basic_continuing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$0.32 | -$0.32 | -$0.32 | -$0.32 | -$0.28 | -$0.28 | -$0.28 | -$0.28 | -$0.28 | $6.44 | $0.01 | -$0.25 | -$0.22 | -$0.29 | -$0.33 | -$0.17 | -$0.38 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +12.7% | +0.0% | +0.0% | +0.0% | -1.8% | >999% | -99.8% | <-999% | +12.0% | -31.8% | -13.8% | +48.5% | -123.5% |
| YoY Change | — | — | — | — | +12.7% | +12.7% | +12.7% | +12.7% | -1.8% | >999% | — | +10.7% | -103.4% | — | <-999% | +32.0% | -72.7% |